colorectal cancer prevalence according to survival data in iran-2007

نویسندگان

farzaneh esna-ashari

mr sohrabi

ar abadi

aa mehrabian

چکیده

abstract objective: colorectal cancer is a common (5000 new cases per year in iran) and lethal disease. regarding the high incidence (7 cases per 100000) and survival rate of colorectal cancer and the priority of prevalence index in cancer management, in this study, 1, 2-3 and 4-5 year point prevalence were determined according to survival data. method: in this study, survival and incidence data were used for the determination of cancer prevalence. incidence data were extracted from cancer registry in iran and survival data were determined during a descriptive study through the follow up of 2342 colorectal cancer patients. 1, 2-3 and 4-5 year point prevalence were estimated from incidence rates in different years and the proportion of patients surviving 0.5, 1.5, 2.5, 3.5 and 4.5 year(s) from diagnosis .  results: proportion of cases surviving 0.5, 1.5, 2.5, 3.5 and 4.5 year(s) from diagnosis were 79.2%, 65.08%, 57.36%, 51.76% and 48.87%, respectively. estimates of 1, 2-3 and 4-5 year prevalence were 4156, 5715 and 4283, respectively. the cumulative 5 year prevalence was 13954 cases. conclusion: these estimates of 1, 2-3 and 4-5 year prevalence are applicable to the evaluation of initial treatment, clinical follow-up and point of cure, respectively. therefore, 1, 2-3 and 4-5 year point prevalence estimates are necessary in health service planning for cancer management.

Sign up for free to access the full text

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Gastric Cancer Prevalence, According To Survival Data in Iran (National Study-2007)

BACKGROUND Gastric cancer is a common and lethal disease throughout the world. In Iran with 7300 new cases annually, it is the first cause of cancer related death in both sexes. Regarding the high incidence (10.5/100000 individuals) of gastric cancer and priority of prevalence index in cancer management, in this study we tried to determine 1, 2-3 and 4-5 year point prevalence of the disease acc...

متن کامل

gastric cancer prevalence, according to survival data in iran (national study-2007)

background : gastric cancer is a common and lethal disease throughout the world. in iran with 7300 new cases annually, it is the first cause of cancer related death in both sexes. regarding the high incidence (10.5/100000 individuals) of gastric can­cer and priority of prevalence index in cancer management, in this study we tried to determine 1, 2-3 and 4-5 year point preva­lence of the disease...

متن کامل

Prevalence of hereditary nonpolyposis colorectal cancer in patients with colorectal cancer in Iran: a systematic review

*Corresponding author: Ladan Goshayeshi. Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. E-mail: [email protected] Tel: 985138012753 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons. org/licenses/by/3.0), which permits unrestricted use, di...

متن کامل

Colorectal Cancer in Northwestern Iran

Background. Colorectal cancer is the third most prevalent cancer worldwide, which is less common in the Middle East; its prevalence demonstrated to be 7 persons per 100,000 populations in Iran. In this study, we aimed to investigate the clinicopathologic features of CRC patients in West Azerbaijan province of Iran. Methods. In this crosssectional study, 546 patients who underwent surgical proce...

متن کامل

Patterns of survival for anatomical sites of colorectal cancer with shift to advanced lesions in Iran.

BACKGROUND With a background of disparities in colorectal cancer (CRC) incidences/mortality across countries due to differences in exposure to various prognostic factors, this study aimed to evaluate the site-specific pattern for the survival of colon and rectal patients. METHODS A total of 1,283 patients with CRC diagnosis according to the pathology report of cancer registry of RCGLD from 1 ...

متن کامل

Economic burden of colorectal cancer in Iran in 2012

    Background: Colorectal cancer is one of the most common cancers in Iran. However little is known about the economic burden associated with this cancer in Iran. The aim of this study was to estimate the economic burden of colorectal cancer in Iran in the year 2012.    Methods: We used the prevalence-based approach and estimated direct and indirect costs of all color...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of cancer prevention

جلد ۲، شماره ۱، صفحات ۱۵-۱۸

کلمات کلیدی
[ ' p r e v a l e n c e ' , ' c o l o r e c t a l ' , ' c a n c e r ' , ' i r a n x a 0 r e f e r e n c e s 1 . l a w r e n c e s d ' , ' a h n e n d j . e p i d e m i o l o g y a n d r i s k f a c t o r s o f c o l o r e c t a l c a n c e r . a v a i l a b l e a t w w w . u p t o d a t e . c o m 2 . ' , ' c e n t e r f o r d i s e a s e c o n t r o l ' , ' d e p u t y o f h e a l t h ' , ' i r a n i a n m i n i s t r y o f h e a l t h a n d m e d i c a l e d u c a t i o n ' , ' n a t i o n a l r e p o r t o n c a n c e r r e g i s t r y . 1 3 8 4 . p u b l i s h e d b y c e n t e r f o r d i s e a s e c o n t r o l . 1 3 8 6 . 3 . c e n t e r f o r d i s e a s e c o n t r o l ' , ' d e p u t y o f h e a l t h ' , ' i r a n i a n m i n i s t r y o f h e a l t h a n d m e d i c a l e d u c a t i o n ' , ' n a t i o n a l r e p o r t o n c a n c e r r e g i s t r y . 1 3 8 2 . p u b l i s h e d b y k e l k e d i r i n p u b l i c a t i o n s . 1 3 8 4 . 4 . c e n t e r f o r d i s e a s e c o n t r o l ' , ' d e p u t y o f h e a l t h ' , ' i r a n i a n x a 0 m i n i s t r y o f h e a l t h a n d m e d i c a l e d u c a t i o n ' , ' n a t i o n a l r e p o r t o n c a n c e r r e g i s t r y . 1 3 8 3 . p u b l i s h e d b y c e n t e r f o r d i s e a s e c o n t r o l . 1 3 8 5 . 5 . c e n t e r f o r n e t w o r k d e v e l o p m e n t a n d h e a l t h p r o m o t i o n a n d a p p l i e d r e s e a r c h s e c r e t a r i a t ' , ' d e p u t y o f h e a l t h ' , ' i r a n i a n x a 0 m i n i s t r y o f h e a l t h a n d m e d i c a l e d u c a t i o n ' , ' d e a t h i n 2 3 p r o v i n c e s o f i r a n . 1 3 8 2 . 6 . p i s a n i p ' , ' b r a y f ' , ' p a r k i n d . m . e s t i m a t e s o f t h e w o r l d ' , ' w i d e p r e v a l e n c e o f c a n c e r f o r 2 5 s i t e s i n t h e a d u l t p o p u l a t i o n . i n t j c a n c e r . 2 0 0 2 ' , 9 7 , 7 2 , ' 8 1 . 7 . r i e s l a g ' , ' h a r k i n s d ' , ' k r a p c h o m ' , ' e t a l . ( e d s ) s e e r c a n c e r s t a t i s t i c s r e v i e w ' , 1 9 7 5 , ' 2 0 0 4 . b e t h e s d a ' , ' m d ' , ' n a t i o n a l c a n c e r i n s t i t u t e ' , ' 2 0 0 6 . a v a i l a b l e a t h t t p ' , ' / / s e e r . c a n c e r . g o v / c s r / 1 9 7 5 _ 2 0 0 4 / ' , ' a c c e s s e d ' , ' 2 0 0 7 . 8 . s a n t m ' , ' c a p o c a c c i a r ' , ' v e r d e c c h i a a ' , ' e t a l . c o m p a r i s o n s o f c o l o n ' , ' c a n c e r s u r v i v a l a m o n g e u r o p e a n c o u n t r i e s ' , ' t h e e u r o c a r e s t u d y . i n t j c a n c e r . 1 9 9 5 ' , ' 6 3 ( 1 ) ' , 4 3 , ' 8 . 9 . l a m b e r t i c ' , ' & ' , ' l t ' , ' a h r e f = & ' , ' q u o t ' , ' h t t p ' , ' / / w w w . n c b i . n l m . n i h . g o v / s i t e s / e n t r e z ? d b = p u b m e d & ' , ' c m d = s e a r c h & ' , ' t e r m = % ' ]

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023